- Media and mobile communications company Digital Turbine Inc APPS will replace Ligand Pharmaceuticals Inc LGND in the S&P MidCap 400.
- Ligand Pharmaceuticals will replace the acquisition target Cincinnati Bell Inc CBB in the S&P SmallCap 600.
- The changes are effective before the opening of trading on September 7.
- Canaccord Genuity analyst Austin Moldow upgraded Digital Turbine from Hold to Buy. Macquarie analyst Tim Nollen initiated coverage on Digital Turbine with a Neutral rating and announced a price target of $60.
- Price Action: APPS shares traded higher by 10.30% at $56.50 in the premarket session on the last check Tuesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
